Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALID II: Pharmacokinetics of paediatric valacyclovir oral solution in children post stem cell transplantation
2017-001451-30Phase 2Terminated
- Sponsor
- Radboud University Medical Center
- Start
- May 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of valaciclovir in herpes simplex (HSV) and Varicella zoster infection, sponsored by Radboud University Medical Center. Primary endpoints: AUC0-12 of acyclovir and Cmax of acyclovir. Started May 2019; status: terminated.
02
Drugs
valaciclovir
03
Conditions
herpes simplex (HSV)Varicella zoster infection
Beyond the preview
Go deeper on 2017-001451-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001451-30.